InvestorsHub Logo

crudeoil24

05/26/16 10:37 PM

#66 RE: otcmoneydoubler #64

Exactly! Big pharma can make $billions from this med once phase III and market approvals by FDA as well as by other countries around the world.
We may get a day of consolidation, but I think it will be off and running again next week. About a dozen tutes added shares earlier this month.
More tutes will want in NERV now. + hedge funds, pension plans, and university endowment funds.
After today's action float may even be below 10M shares now.
Maybe Baker Bros bought in today. Expect to see a 13-G some form 3'and 4's.
NERV may be going a lot higher even before FDA phase III approval.

I have link on tutes ownership in an earlier post.